Concepedia

Bob Anders

BA

Statistics

Publications

3

Citations

70

H-Index

3

Active since

2014

Affiliations

Upsher-Smith Laboratories (United States)(Current)

Bob Anders is an author at Upsher-Smith Laboratories (United States) specializing in pharmacology, drug disposition, and neuropharmacology.

Publications per year

2014–2016

3

Publications

3

Once‐daily <scp>USL</scp>255 as adjunctive treatment of partial‐onset seizures: Randomized phase <scp>III</scp> study

Steve Chung, Toufic Fakhoury, R. Edward Hogan et al. · Epilepsia · 2014 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate

Barry E. Gidal, Annie Clark, Bob Anders et al. · Epilepsy Research · 2016 · 25 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes

Annie Clark, John M. Pellock, Mary Holmay et al. · Epilepsy & Behavior · 2016 · 10 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

1–3 of 3